| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/03/1997 | WO1997023230A1 Method of treating disorders characterized by overexpression of cytidine deaminase or deoxycytidine deaminase |
| 07/03/1997 | WO1997023228A2 Contraceptive process and kit for female mammals, comprising a combination of gestagen and oestrogen |
| 07/03/1997 | WO1997023227A1 Transdermal estradiol/progestogen agent patch and its production |
| 07/03/1997 | WO1997023226A1 Combinations of prostaglandins and miotics for lowering intraocular pressure |
| 07/03/1997 | WO1997023225A1 Combinations of dp and fp type prostaglandins for lowering iop |
| 07/03/1997 | WO1997023224A1 Use of 3-oxa-d-prostaglandins for the manufacture of a medicament for the treatment of glaucoma |
| 07/03/1997 | WO1997023223A1 Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives |
| 07/03/1997 | WO1997023222A1 Use of certain isoquinolinesulfonyl compounds for the treatment of glaucoma and ocular ischemia |
| 07/03/1997 | WO1997023221A1 Method for treating dermatitis |
| 07/03/1997 | WO1997023220A1 Method for treating depression |
| 07/03/1997 | WO1997023219A1 Sustained-release microgranules containing diltiazem as the active principle |
| 07/03/1997 | WO1997023218A1 A process for regulating vagal tone |
| 07/03/1997 | WO1997023217A1 Injectable quinolone formulations |
| 07/03/1997 | WO1997023215A1 2-substituted piperidine analogs and their use as subtype-selective nmda receptor antagonists |
| 07/03/1997 | WO1997023214A1 4-substituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
| 07/03/1997 | WO1997023213A1 Process for production of piperidine derivatives |
| 07/03/1997 | WO1997023212A1 ISOXAZOLINE, ISOTHIAZOLINE AND PYRAZOLINE FACTOR Xa INHIBITORS |
| 07/03/1997 | WO1997023211A1 Pharmaceutical compounds |
| 07/03/1997 | WO1997023210A1 Antiobestic agent containing procyanidin as the active ingredient |
| 07/03/1997 | WO1997023209A1 Therapeutic agent for cardiac failure |
| 07/03/1997 | WO1997023208A1 Taxane composition and method |
| 07/03/1997 | WO1997023207A1 Anti-helicobacter pylori agent |
| 07/03/1997 | WO1997023206A1 Drug delivery device |
| 07/03/1997 | WO1997023205A1 Transdermal device for the delivery of flurbiprofen |
| 07/03/1997 | WO1997023204A1 Nitric oxide (no) synthase inhibitor to treat or prevent type ii diabetes |
| 07/03/1997 | WO1997023203A1 Aminoguanidine for treating niddm |
| 07/03/1997 | WO1997023201A1 Dietary fiber delivery system |
| 07/03/1997 | WO1997023200A1 Pharmaceutical composition stabilized with a basic agent |
| 07/03/1997 | WO1997023199A1 Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases |
| 07/03/1997 | WO1997023198A1 A cosmetic composition and a method for reducing the ageing processes of skin |
| 07/03/1997 | WO1997016185A3 A pharmaceutical composition for the treatment of autoimmune diseases |
| 07/03/1997 | WO1997015300A3 Use of 4-amino-4-(4-fluorobenzylamino)-1-ethoxy-carbonylaminobenzene for prophylaxis and treatment of sequelae of acute and chronic reduced circulation in the brain and neurodegenerative disorders |
| 07/03/1997 | WO1997011692A3 Protein tyrosine kinase inhibitors for treating osteoarthritis |
| 07/03/1997 | DE19548812A1 Verwendung von Inhibitoren des zellulären Na·+·/H·+·-Exchangers (NHE) zur Herstellung eines Medikaments zur Atemstimulation Use of inhibitors of the cellular Na + · · / · H + · -Exchangers (NHE) for the production of a medicament for respiratory stimulation |
| 07/03/1997 | DE19548709A1 Tyrosinderivate Tyrosine derivatives |
| 07/03/1997 | CA2241924A1 Methods for measurement and treatment predicated on the presence of advanced glycosylation endproducts in tobacco and its combustion byproducts |
| 07/03/1997 | CA2241746A1 N-acylaminoalkylhydrazinecarboximidamides |
| 07/03/1997 | CA2241688A1 Imides as pde iii, pde iv and tnf inhibitors |
| 07/03/1997 | CA2241255A1 Method of treating disorders characterized by overexpression of cytidine deaminase or deoxycytidine deaminase |
| 07/03/1997 | CA2241205A1 Pharmaceutical compositions with vitamin d analogues |
| 07/03/1997 | CA2241192A1 Contraceptive process and kit for female mammals that consists of a combination of gestagen and estrogen |
| 07/03/1997 | CA2241153A1 Method for treating depression |
| 07/03/1997 | CA2241149A1 Tyrosin-derivate as alpha-v-integrin inhibitors |
| 07/03/1997 | CA2241143A1 Heterocyclyl-condensed benzoylguanidines, their production and use as inhibitors of the cellular na+/h+-antiporter |
| 07/03/1997 | CA2241129A1 Therapeutic compositions |
| 07/03/1997 | CA2241105A1 Staphylococcus aureus coenzyme a disulfide reductase, and inhibitors thereof useful as antimicrobial agents |
| 07/03/1997 | CA2241086A1 Pharmaceutical compounds |
| 07/03/1997 | CA2241023A1 Novel polynucleotides and polypeptides in pathogenic mycobacteria and their use as diagnostics, vaccines and targets for chemotherapy |
| 07/03/1997 | CA2241011A1 17-side chain alkynyl-and 20-oxopregna-derivatives of vitamin d, methods for their production and pharmaceutical compositions thereof |
| 07/03/1997 | CA2240941A1 Galactopyranosides and their use |
| 07/03/1997 | CA2240836A1 Method for treating dermatitis |
| 07/03/1997 | CA2240834A1 Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines |
| 07/03/1997 | CA2240767A1 Water soluble antibiotics |
| 07/03/1997 | CA2240595A1 Taxane composition and method |
| 07/03/1997 | CA2240505A1 A cosmetic composition and a method for reducing the ageing processes of skin |
| 07/03/1997 | CA2240492A1 Aminoguanidine for treating niddm |
| 07/03/1997 | CA2240439A1 Novel integrin receptor antagonists |
| 07/03/1997 | CA2240396A1 Nitric oxide (no) synthase inhibitor to treat or prevent type ii diabetes |
| 07/03/1997 | CA2240349A1 Drug delivery device |
| 07/03/1997 | CA2240038A1 4-substituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
| 07/03/1997 | CA2239909A1 Use of toxin peptides and/or affinity handles for the delivering compounds into cells |
| 07/03/1997 | CA2239711A1 Compounds with growth hormone releasing properties |
| 07/03/1997 | CA2239682A1 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof |
| 07/03/1997 | CA2239162A1 Novel compounds with analgesic effect |
| 07/03/1997 | CA2239010A1 Transdermal estradiol/progestogen agent patch and its production |
| 07/03/1997 | CA2238877A1 Biologically active benzothiazolone ethanamines |
| 07/03/1997 | CA2238873A1 Cell activation process and reagents therefor |
| 07/03/1997 | CA2238737A1 Prodrugs of thrombin inhibitors |
| 07/03/1997 | CA2238635A1 Trans apovincaminic acid ester derivatives as drugs |
| 07/03/1997 | CA2238400A1 Transdermal device for the delivery of flurbiprofen |
| 07/03/1997 | CA2237543A1 New form of amphiregulin, methods for producing and using the same and compositions comprising the same |
| 07/03/1997 | CA2236096A1 Aromatic keto-acids and their derivatives as inhibitors of matrix metalloproteinases |
| 07/03/1997 | CA2213489A1 Carbohydrate conjugated bio-active compounds |
| 07/02/1997 | EP0782016A2 Contact lens containing a leachable absorbed material |
| 07/02/1997 | EP0781778A1 Novel paclitaxel prodrugs, method for preparation as well as their use in selective chemotherapy |
| 07/02/1997 | EP0781776A2 Water soluble rapamycin esters |
| 07/02/1997 | EP0781774A2 Prolactin production inhibitory agents |
| 07/02/1997 | EP0781766A1 Heterocyclic derivative and medicine |
| 07/02/1997 | EP0781756A1 Soluble concentrated frozen/refrigerated calcium preparation comprising calcium citrate malate and process for producing the same |
| 07/02/1997 | EP0781561A1 Novel medicinal use of 5ht 3? antagonist |
| 07/02/1997 | EP0781557A1 Use of suleparoide in the prevention of endothelitis and other endothelial reactions induced by therapeutic intravenous infusions |
| 07/02/1997 | EP0781556A1 Use of condensed dihydropyridines for the treatement of chronic inflammatory processes |
| 07/02/1997 | EP0781555A1 Benzothiophene formulations of a specific dosage |
| 07/02/1997 | EP0781554A1 Hydroxyl radical scavenger |
| 07/02/1997 | EP0781553A1 Patch for external use |
| 07/02/1997 | EP0781552A1 Multidrug resistance inhibitors |
| 07/02/1997 | EP0781551A1 Retinoid formulations in porous microspheres for reduced irritation and enhanced stability |
| 07/02/1997 | EP0781550A1 Bioadhesive pharmaceutical composition for the controlled release of active agents |
| 07/02/1997 | EP0781547A1 Sodium hyaluronate based ophthalmic formulation for use in eye surgery |
| 07/02/1997 | EP0781546A1 A multi-layered film preparation |
| 07/02/1997 | EP0781336A1 A human map kinase homolog |
| 07/02/1997 | EP0781332A2 Enhancement of oligonucleotide inhibition of protein production, cell proliferation, and/or multiplication of infectious disease pathogens |
| 07/02/1997 | EP0781286A1 7,7-disubstituted cephem-4-ketones |
| 07/02/1997 | EP0781285A1 Fused indole and quinoxaline derivatives, their preparation and use |
| 07/02/1997 | EP0781284A1 Indole-2,3-dione-3-oxime derivatives, their preparation and use |
| 07/02/1997 | EP0781283A1 Triazolopyridazines process and intermediates for their preparation and their use as medicaments |
| 07/02/1997 | EP0781282A1 [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE |
| 07/02/1997 | EP0781281A1 NOVEL MELATONIN AGONIST $g(b)-CARBOLINE DERIVATIVES AND ANALOGS WITH A NAPHTHALENIC STRUCTURE, METHOD FOR THEIR PREPARATION AND THEIR USE AS DRUGS |
| 07/02/1997 | EP0781280A1 Derivatives of benzopyran and of benzothiopyran, their preparation and their use as agonists of dopaminergic receptors |
| 07/02/1997 | EP0781279A1 Quinoxalinedione nmda receptor antagonists |